Breast cancer remains the most prevalent malignancy among women globally, with endocrine therapy representing the cornerstone of treatment for hormone receptor-positive subtypes. However, the emergence of therapeutic resistance poses significant clinical challenges. This narrative review presents a comprehensive computational framework integrating mathematical modeling, systems biology, and clinical pharmacology to understand hormonal dynamics in breast cancer progression and treatment response.
Jain et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: